Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-04-11

Clinical Trial Update: Treximet ™ Pharmacy Budget Impact Model Database Validation Study

View source ↗

Summary

Completed study validating a budget impact model database for Treximet (sumatriptan/naproxen) in migraine disorders; results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Migraine Disorders | Status: COMPLETED | Results posted: 2011-04-11